CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dr.Reddy's Laboratories Ltd Company Snapshot
Dr.Reddy's Laboratories Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dr.Reddy's Laboratories Ltd with three other companies in this sector in India: Aurobindo Pharma Ltd (2018 sales of 164.63 billion Indian Rupees [US$2.39 billion] ), Cipla Ltd (151.56 billion Indian Rupees [US$2.20 billion] of which 100% was Pharmaceuticals), and Lupin Ltd (158.04 billion Indian Rupees [US$2.29 billion] of which 100% was Pharmaceuticals).

Sales Analysis. Dr.Reddy's Laboratories Ltd reported sales of 142.03 billion Indian Rupees (US$2.06 billion) for the fiscal year ending March of 2018. This represents a very small increase of 0.9% versus 2017, when the company's sales were 140.81 billion Indian Rupees. Despite this increase, sales are still below the level achieved in 2016, when Dr.Reddy's Laboratories Ltd reported sales of 154.71 billion Indian Rupees. Sales of Formulations/propreietary Products saw an increase that was more than double the company's growth rate: sales were up 79.6% in 2018, from 2.36 billion Indian Rupees to 4.25 billion Indian Rupees. Dr.Reddy's Laboratories Ltd also saw significant increases in sales in Active Pharmaceutical Ingredients and In (up 3.4% to 21.99 billion Indian Rupees) . Not all segments of Dr.Reddy's Laboratories Ltd experienced an increase in sales in 2018: sales of Global Generics fell 1.2% to 114.01 billion Indian Rupees.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Dr.Reddy's Laboratories Ltd
  Stock Performance Chart for Dr.Reddy's Laboratories Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (8/10/2018): 2,214.30
(Figures in Indian Rupees)
1 Week -2.9%   13 Weeks -4.5%  
4 Weeks 11.2%   52 Weeks 10.1%  
 
Dr.Reddy's Laboratories Ltd Key Data:
  Ticker: DRREDDY Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 142,028,000,000
(Year Ending Jan 2019).
Employees: 23,524
  Currency: Indian Rupees Market Cap: 367,419,233,003
  Fiscal Yr Ends: March Shares Outstanding: 165,930,196
  Share Type: Ordinary Closely Held Shares: 43,710,318
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.